 SOUTH SAN FRANCISCO, Calif., Aug. 16, 2021 GLOBE NEWSWIRE -- Vera Therapeutics, Inc. Nasdaq: VERA, a clinical-stage biotechnology company focused on developing treatments for immunological diseases that improve patients lives, today reported its financial results for the second quarter ended June 30, 2021 and provided a corporate update. 